Safety and Efficacy of BRM421 for Dry Eye Syndrome Treatment
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Blair Boehmer, MD
Midwest Cornea Associates, LLC.
Principal Investigator - David Wirta, MD
Eye Research Foundation
Principal Investigator - Eugene B McLaurin, MD
Total Eye Care, PA
Principal Investigator - Gail Torkildsen, MD
Andover Eye Associates
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Eye Research Foundation
Newport Beach, California, United States
- Midwest Cornea Associates, Llc
Indianapolis, Indiana, United States
- Andover Eye Associates
Andover, Massachusetts, United States
- Total Eye Care
Memphis, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Jan 2020
- Primary completion
- 23 Jun 2020
- Completion
- 23 Jun 2020
- Last update posted
- 1 May 2026
- Registered enrollment
- 220
- Registry id
- NCT04343287
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.